222 related articles for article (PubMed ID: 19925953)
21. [Safety and efficacy of an antirabies vaccine consisting of recombinant vaccinia-rabies virus administered orally to the fox, dog and cat].
Blancou J; Artois M; Brochier B; Thomas I; Pastoret PP; Desmettre P; Languet B; Kiény MP
Ann Rech Vet; 1989; 20(2):195-204. PubMed ID: 2751231
[TBL] [Abstract][Full Text] [Related]
22. Target and non-target effects of a recombinant vaccinia-rabies virus developed for fox vaccination against rabies.
Pastoret PP; Brochier B; Boulanger D
Dev Biol Stand; 1995; 84():183-93. PubMed ID: 7796953
[No Abstract] [Full Text] [Related]
23. Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB) in target and non-target species.
Knowles MK; Nadin-Davis SA; Sheen M; Rosatte R; Mueller R; Beresford A
Vaccine; 2009 Nov; 27(47):6619-26. PubMed ID: 19698811
[TBL] [Abstract][Full Text] [Related]
24. Rabies eradication in Belgium by fox vaccination using vaccinia-rabies recombinant virus.
Brochier B; Pastoret PP
Onderstepoort J Vet Res; 1993 Dec; 60(4):469-75. PubMed ID: 7777338
[TBL] [Abstract][Full Text] [Related]
25. Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3).
Shen CF; Lanthier S; Jacob D; Montes J; Beath A; Beresford A; Kamen A
Vaccine; 2012 Jan; 30(2):300-6. PubMed ID: 22079076
[TBL] [Abstract][Full Text] [Related]
26. Live poxvirus-vectored vaccines in wildlife immunization programmes: the rabies paradigm.
Esposito JJ
Res Virol; 1989; 140(5):480-2; discussion 487-91. PubMed ID: 2587854
[No Abstract] [Full Text] [Related]
27. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
Xiang ZQ; Yang Y; Wilson JM; Ertl HC
Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
[TBL] [Abstract][Full Text] [Related]
28. Recombinant rabies vaccines: efficacy assessment in free-ranging animals.
Rupprecht CE; Hanlon CA; Niezgoda M; Buchanan JR; Diehl D; Koprowski H
Onderstepoort J Vet Res; 1993 Dec; 60(4):463-8. PubMed ID: 7777337
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and safety of recombinant rabies viruses used for oral vaccination of stray dogs and wildlife.
Faber M; Dietzschold B; Li J
Zoonoses Public Health; 2009 Aug; 56(6-7):262-9. PubMed ID: 19486317
[TBL] [Abstract][Full Text] [Related]
30. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
[TBL] [Abstract][Full Text] [Related]
31. A recombinant vaccinia-rabies virus in the immunocompromised host: oral innocuity, progressive parenteral infection, and therapeutics.
Hanlon CA; Niezgoda M; Shankar V; Niu HS; Koprowski H; Rupprecht CE
Vaccine; 1997 Feb; 15(2):140-8. PubMed ID: 9066030
[TBL] [Abstract][Full Text] [Related]
32. Elimination of terrestrial rabies in Western European countries.
Cliquet F; Aubert M
Dev Biol (Basel); 2004; 119():185-204. PubMed ID: 15747421
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo genetic stability studies of a human adenovirus type 5 recombinant rabies glycoprotein vaccine (ONRAB).
Knowles MK; Roberts D; Craig S; Sheen M; Nadin-Davis SA; Wandeler AI
Vaccine; 2009 May; 27(20):2662-8. PubMed ID: 19428876
[TBL] [Abstract][Full Text] [Related]
34. [Oral vaccination in the control of feral rabies].
Biocca E; Bellani L
Parassitologia; 1988; 30(1):3-12. PubMed ID: 3268770
[TBL] [Abstract][Full Text] [Related]
35. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies.
Hu RL; Liu Y; Zhang SF; Zhang F; Fooks AR
Vaccine; 2007 Jul; 25(29):5301-7. PubMed ID: 17576027
[TBL] [Abstract][Full Text] [Related]
36. A field trial in Belgium to control fox rabies by oral immunisation.
Brochier B; Thomas I; Iokem A; Ginter A; Kalpers J; Paquot A; Costy F; Pastoret PP
Vet Rec; 1988 Dec; 123(24):618-21. PubMed ID: 3218039
[TBL] [Abstract][Full Text] [Related]
37. Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control.
Rupprecht CE; Hanlon CA; Slate D
Dev Biol (Basel); 2004; 119():173-84. PubMed ID: 15742629
[TBL] [Abstract][Full Text] [Related]
38. Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines.
Franka R; Wu X; Jackson FR; Velasco-Villa A; Palmer DP; Henderson H; Hayat W; Green DB; Blanton JD; Greenberg L; Rupprecht CE
Vaccine; 2009 Nov; 27(51):7149-55. PubMed ID: 19925945
[TBL] [Abstract][Full Text] [Related]
39. Animal poxvirus vaccines: a comprehensive review.
Bhanuprakash V; Hosamani M; Venkatesan G; Balamurugan V; Yogisharadhya R; Singh RK
Expert Rev Vaccines; 2012 Nov; 11(11):1355-74. PubMed ID: 23249235
[TBL] [Abstract][Full Text] [Related]
40. Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein.
Esposito JJ; Knight JC; Shaddock JH; Novembre FJ; Baer GM
Virology; 1988 Jul; 165(1):313-6. PubMed ID: 3291388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
